Medexus Pharmaceuticals Inc
TSX:MDP

Watchlist Manager
Medexus Pharmaceuticals Inc Logo
Medexus Pharmaceuticals Inc
TSX:MDP
Watchlist
Price: 2.87 CAD 0.7% Market Closed
Market Cap: 92.6m CAD

Gross Margin
Medexus Pharmaceuticals Inc

52.6%
Current
54%
Average
48.5%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
52.6%
=
Gross Profit
55.5m
/
Revenue
105.7m

Gross Margin Across Competitors

Medexus Pharmaceuticals Inc
Glance View

Market Cap
92.6m CAD
Industry
Pharmaceuticals

Medexus Pharmaceuticals, Inc. operates as a pharmaceutical company, which provides healthcare products to Healthcare Professionals and patients and focuses on therapeutic areas of auto-immune disease and pediatrics. The company is headquartered in Bolton, Ontario and currently employs 79 full-time employees. The company went IPO on 2012-03-03. The firm is a North American focused, specialty pharmaceutical business that operates through two divisions: Medexus Pharma Canada and Medexus Pharma USA. Medexus Pharma Canada, a fully integrated commercial infrastructure focused on rheumatology, allergy, auto-immune disease, specialty oncology and pediatric diseases in Canada. Medexus Pharma USA, a fully integrated commercial infrastructure focused on rheumatology and auto-immune diseases in the United States (U.S). The firm is focused on the therapeutic areas of auto-immune disease, hematology, pediatrics, dermatology and allergy. The firm's products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases. The company also offers IXINITY, a medicine for use in patients 12 years of age or older with Hemophilia B and Rupall, an allergy medication.

MDP Intrinsic Value
9.98 CAD
Undervaluation 71%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
52.6%
=
Gross Profit
55.5m
/
Revenue
105.7m
What is the Gross Margin of Medexus Pharmaceuticals Inc?

Based on Medexus Pharmaceuticals Inc's most recent financial statements, the company has Gross Margin of 52.6%.

Back to Top